Tasquinimod
Selleck Chemicals
SKU:S7617-5MG
Couldn't load pickup availability

Tasquinimod is an inhibitor of HDAC used in studies of Epigenetic Regulation. It is especially relevant in angiogenesis, cancer, and epigenetics models, where defined compound exposure can be linked to chromatin-state control, histone modification, and transcriptional regulation.
By inhibiting HDAC, Tasquinimod can be used to examine chromatin-state control, histone modification, and transcriptional regulation. The epigenetic regulator annotation adds relevance to chromatin, epigenetic, and gene-expression profiling, together with downstream-response mapping in the same experimental setting. In angiogenesis, cancer, and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving HDAC
- Pathway perturbation studies connected to Epigenetic Regulation
- Concentration-response inhibition and target-dependence studies
- Chromatin, epigenetic, and gene-expression profiling
Overall, Tasquinimod is appropriate when a defined chemical perturbant is needed to connect HDAC with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in angiogenesis, cancer, and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- HDAC
- Target Class:
- Epigenetic Regulator
- Pathways:
- Epigenetic Regulation
- Research Area:
- Angiogenesis • Cancer • Epigenetics
- CAS No.:
- 254964-60-8
- Molecular Weight:
- 406.36
- Formula:
- C₂₀H₁₇F₃N₂O₄
- SMILES:
- CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.